Electrocore, Inc. (ECOR) — 8-K Filings
All 8-K filings from Electrocore, Inc.. Browse 12 Current Event Report reports with AI-powered summaries and risk analysis.
8-K Filings (12)
-
electroCore, Inc. Files 8-K Report
— Oct 3, 2025 Risk: low
On September 30, 2025, electroCore, Inc. filed an 8-K report. The filing pertains to 'Other Events' and was submitted on October 3, 2025. No specific financial -
electroCore, Inc. Files 8-K: Director Changes & Officer Compensation Updates
— Sep 3, 2025 Risk: medium
On September 2, 2025, electroCore, Inc. filed an 8-K report detailing several key events. The company announced the election of new directors, changes in certai -
electroCore Acquires Protalix BioTherapeutics Assets
— May 2, 2025 Risk: medium
On May 1, 2025, electroCore, Inc. announced the completion of its acquisition of substantially all of the assets of Protalix BioTherapeutics, Inc. The transacti -
electroCore, Inc. Files 8-K on Accountant Change
— Apr 3, 2025 Risk: low
On April 1, 2025, electroCore, Inc. filed an 8-K report. The filing primarily concerns changes in the registrant's certifying accountant and includes financial -
electroCore, Inc. Reports Board and Executive Changes
— Feb 28, 2025 Risk: medium
On February 24, 2025, electroCore, Inc. filed an 8-K report detailing changes in its board of directors and executive compensation. The filing indicates the dep -
electroCore, Inc. Files 8-K on Financials
— Jan 17, 2025 Risk: medium
electroCore, Inc. filed an 8-K on January 17, 2025, reporting on its results of operations and financial condition. The filing also includes information related -
electroCore, Inc. Files 8-K with Material Agreement Details
— Dec 17, 2024 Risk: medium
On December 17, 2024, electroCore, Inc. filed an 8-K report detailing a material definitive agreement. The filing also includes Regulation FD disclosures and fi -
electroCore, Inc. Files 8-K for Material Agreement
— Nov 29, 2024 Risk: medium
On November 29, 2024, electroCore, Inc. filed an 8-K report detailing the entry into a material definitive agreement. The filing also includes financial stateme -
ElectroCore Appoints New CMO, Elects Director
— Sep 6, 2024 Risk: medium
ElectroCore, Inc. announced on September 3, 2024, the appointment of Dr. Peter J. McKenna as Chief Medical Officer and the election of Ms. Karen L. King to its -
electroCore Appoints New CMO, Elects Director
— Jul 17, 2024 Risk: low
On July 11, 2024, electroCore, Inc. announced the appointment of Dr. Francis R. Smith as Chief Medical Officer and the election of Ms. Jennifer L. Smith to its -
electroCore Sells $1M in Stock to Accredited Investor
— Jun 3, 2024 Risk: medium
On May 31, 2024, electroCore, Inc. entered into a Material Definitive Agreement, specifically a Securities Purchase Agreement, with an accredited investor. This -
electroCore Raises $7.5M in Common Stock Offering
— Jan 16, 2024
electroCore, Inc. filed an 8-K on January 16, 2024, to report on its financial condition and operations, specifically regarding a public offering of 10,000,000
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX